SCHEMBL4331301

SCHEMBL4331301

CC(=O)NC(C(N)=O)n1nc(-c2cc3ccccc3o2)c2c(F)c(C(=O)O)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 9/20 0.41
ALDH1A1 P00352 7/20 0.41
TDP1 Q9NUW8 1/20 0.41
MEN1 O00255 8/20 0.38
KMT2A Q03164 8/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
MAPT P10636 5/20 0.38
POLB P06746 2/20 0.38
MAPK1 P28482 1/20 0.38
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
NPSR1 Q6W5P4 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
GAA P10253 2/20 0.37
SIRT6 Q8N6T7 1/20 0.35
SYK P43405 1/20 0.35
JAK2 O60674 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4332493 0.81 IKBKB (0.36) JAK2JAK3PLAU
SCHEMBL4341027 0.80 KDM4E (0.40) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4334945 0.79 CSNK1E (0.38) JAK2JAK3
SCHEMBL2864978 0.74 KDM4E (0.46) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4334570 0.72 KDM4E (0.39) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4341551 0.69 ALDH1A1 (0.37) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2871263 0.69 KDM4E (0.41) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL4331228 0.68 KDM4E (0.36) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2872600 0.67 KDM4E (0.45) KDM4EALDH1A1TDP1MEN1KMT2A
SCHEMBL2864981 0.67 KDM4E (0.39) KDM4EALDH1A1TDP1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 KDM4E 2531/4885ALDH1A1 1588/4885TDP1 3905/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.